Home LiteratureArticle Details
PMID: 8521619 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence.

Clinical & experimental metastasis ·Vol. 14 ·No. 1 ·1996-01-00 ·Pages 73-82

Kogerman P, Sy MS, Culp LA

Abstract

Oncogene-dependent regulation and tumor relatedness of CD44 expression were investigated in Balb/c 3T3 cells and their derivatives transformed with different ras oncogenes (metastatic tumor model) or the human c-sis oncogene (non-metastatic model). Ras transformants using either the Harvey or Kirsten oncogenes expressed high levels of cell surface CD44 protein that bound fluoresceinated hyaluronan (HA). Much lower levels of CD44 were expressed in parental 3T3 cells, ras- revertants generated from Kirsten-transformed cells, or c-sis transformants, confirming the significance of the ras oncogene in this upregulation. To determine whether endogenous HA regulates these parameters, hyaluronidase treatment of ras transformants exposed more cell surface CD44 to anti-CD44 antibody and increased fluoresceinated HA binding; this did not occur with 3T3 or c-sis transformants. CD44 expression and its HA-binding function were conserved in a panel of in vivo primary and lung metastatic tumor cell lines derived from ras transformants. Ras transformants also retained the ability to downregulate CD44 protein levels in confluent cultures which occurred through a translational or post-translational mechanism (as CD44 mRNA levels were not reduced). These results taken together demonstrate that ras-dependent regulation of CD44 may correlate with tumor progression and metastasis in vivo, possibly (although not exclusively) supporting CD44's importance in metastatic progression.

MeSH Terms
3T3 Cells Animals Blotting, Western Cell Line, Transformed Gene Expression Regulation, Neoplastic Genes, ras Humans Hyaluronan Receptors/drug effects,genetics,metabolism Hyaluronic Acid/metabolism Hyaluronoglucosaminidase/pharmacology Mice Mice, Inbred BALB C Mice, Nude Oncogenes Tumor Cells, Cultured
Chemicals
Hyaluronan Receptors Hyaluronic Acid Hyaluronoglucosaminidase
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kogerman P
Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Sy M S
Culp L A
References (36)
36 references, click to expand
  1. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.
    Cancer Metastasis Rev. 1988 Jun;7(2):143-88 PMID: 3293836
  2. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
    Cell Immunol. 1993 Nov;152(1):186-99 PMID: 7694807
  3. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.
    J Cell Physiol. 1994 Aug;160(2):275-86 PMID: 7518822
  4. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  5. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.
    J Exp Med. 1990 Jul 1;172(1):69-75 PMID: 2193100
  6. Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells.
    Oncogene. 1994 Feb;9(2):417-23 PMID: 7507229
  7. Distinct effects of two CD44 isoforms on tumor growth in vivo.
    J Exp Med. 1991 Oct 1;174(4):859-66 PMID: 1919439
  8. Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.
    Br J Cancer. 1993 May;67(5):910-21 PMID: 8494724
  9. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression.
    Proc Natl Acad Sci U S A. 1987 Aug;84(15):5143-7 PMID: 3474646
  10. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior.
    Cancer Res. 1993 Mar 15;53(6):1262-8 PMID: 8443806
  11. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation.
    Cell. 1995 Jul 14;82(1):19-26 PMID: 7541721
  12. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Cancer Res. 1994 Jul 15;54(14):3922-8 PMID: 7518345
  13. Significance of CD44 gene products for cancer diagnosis and disease evaluation.
    Lancet. 1992 Oct 31;340(8827):1053-8 PMID: 1357452
  14. Topological and quantitative-analyses of early events in tumor-formation using histochemically-tagged transformed 3t3 cells.
    Oncol Rep. 1994 Sep;1(5):869-76 PMID: 21607457
  15. The hyaluronate synthase from a eukaryotic cell line.
    Biochem J. 1993 Mar 15;290 ( Pt 3):791-5 PMID: 8457208
  16. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Cancer Res. 1993 Sep 15;53(18):4197-203 PMID: 7689929
  17. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.
    Cell. 1991 Apr 5;65(1):13-24 PMID: 1707342
  18. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
    Cancer Res. 1993 Apr 1;53(7):1516-21 PMID: 8453616
  19. Putative preneoplastic foci in the human prostate.
    J Cell Biochem Suppl. 1994;19:224-31 PMID: 7529854
  20. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Cancer Res. 1994 Aug 1;54(15):4238-42 PMID: 7518353
  21. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
    Exp Cell Res. 1993 Aug;207(2):277-82 PMID: 7688314
  22. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
    Cancer Res. 1993 Oct 15;53(20):4754-6 PMID: 7691404
  23. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
    Cancer Res. 1988 Sep 1;48(17):4941-53 PMID: 3409227
  24. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis.
    Exp Cell Res. 1993 Feb;204(2):171-80 PMID: 8382620
  25. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Cancer Res. 1994 Aug 15;54(16):4539-46 PMID: 7519124
  26. CD44 and its interaction with extracellular matrix.
    Adv Immunol. 1993;54:271-335 PMID: 8379464
  27. High-resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes.
    Am J Pathol. 1992 Dec;141(6):1331-42 PMID: 1466397
  28. CD44--a new prognostic marker for neuroblastoma.
    N Engl J Med. 1993 Dec 23;329(26):1965 PMID: 7504209
  29. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44.
    Cancer Res. 1991 Dec 15;51(24):6660-7 PMID: 1742741
  30. Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression.
    Cancer Res. 1990 May 1;50(9):2808-17 PMID: 2183931
  31. The implications of angiogenesis for the biology and therapy of cancer metastasis.
    Cell. 1994 Oct 21;79(2):185-8 PMID: 7525076
  32. Clonal dominance of select subsets of viral Kirsten ras(+)-transformed 3T3 cells during tumor progression.
    Int J Cancer. 1991 Apr 22;48(1):148-59 PMID: 2019453
  33. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures.
    J Exp Med. 1990 Feb 1;171(2):477-88 PMID: 2406365
  34. Modulation of tumor cell response to chemotherapy by the organ environment.
    Cancer Metastasis Rev. 1994 Jun;13(2):209-22 PMID: 7923551
  35. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.
    J Cell Biol. 1992 Feb;116(4):1055-62 PMID: 1370836
  36. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
    Cancer Res. 1994 Mar 15;54(6):1561-5 PMID: 7511044
Article Info
Journal
Clinical & experimental metastasis
Abbr.
Clin Exp Metastasis
ISSN
0262-0898
Published
1996-01-00
Pages
73-82
Language
English
Region
Netherlands
NLM ID
8409970
Subset
IM
Grants
NCI NIH HHS · CA27755 · United States
NCI NIH HHS · CA60469 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com